Frequently Asked Questions

CTECH Labs is an Indonesian research and technology company specialising in capacitive field science. We develop, manufacture, and deploy technologies across four domains: industrial process imaging, non-destructive material inspection, cancer therapy, and human performance. Every product we build originates from the same core science — applied capacitive fields — developed and manufactured entirely in-house.

CTECH Labs is headquartered in Tangerang, Banten, Indonesia. Our facilities include a dedicated research laboratory and manufacturing centre at Modern Business Park 9K, Tangerang 15141. We operate internationally through partnerships and institutional collaborations.

We operate across four domains: industrial imaging and process monitoring, non-destructive material inspection, medical physics and cancer therapy, and sport technology and cellular health. All of these are grounded in the same foundational science of capacitive fields developed by our research team over two decades.

You can reach us via our contact page. For partnership and collaboration enquiries, our team typically responds within 2–3 business days.

Electrical Capacitance Volume Tomography (ECVT) is a 3D imaging technology that uses capacitance sensors to reconstruct the internal distribution of materials in a volume — non-invasively and without radiation. ECVT can image the interior of opaque vessels, pipelines, and biological structures in real time, making it suitable for both industrial process monitoring and clinical imaging applications.

Electrical Capacitance Cancer Therapy (ECCT) is a non-invasive cancer treatment modality that applies low-level, capacitively coupled electric fields directly to tumour tissue. These fields interfere with cancer cell division at the mitotic stage without affecting healthy tissue, and are used alongside — rather than instead of — standard oncology treatments such as chemotherapy and radiotherapy. Clinical data has demonstrated significant improvements in survival rates for select cancer types.

Electrical Capacitance Bio-Stimulation (ECBS) applies capacitive electric fields to biological tissue to promote cellular recovery, performance, and conditioning. It is primarily used in sport and wellness settings to accelerate post-exertion recovery and enhance cellular membrane function — with potential broader applications in clinical rehabilitation.

All three technologies — ECVT, ECCT, and ECBS — are applications of the same foundational physics: capacitive field generation and interaction with matter. They differ in how the fields are shaped, directed, and applied, but share the same sensor and signal architecture. This shared foundation means advances in one area often inform the others, and our manufacturing process is unified across all product lines.

ECVT is used across oil and gas, petrochemical, cement and mining, food processing, and manufacturing industries — anywhere that real-time, non-invasive volumetric imaging of internal process flows or material distributions is needed. It is particularly valuable in pipelines, reactors, and vessels where contact-based or radiative methods are impractical or unsafe.

No. ECVT sensors are mounted externally around the vessel or pipeline. The capacitive fields penetrate the vessel wall and interact with the material inside without any physical contact with the process stream. This makes ECVT suitable for high-temperature, high-pressure, corrosive, or otherwise hostile process environments.

ECVT has several advantages over X-ray CT and ultrasound in industrial settings: it is radiation-free (no safety exclusion zones or regulatory restrictions), operates in real time at high frame rates, can penetrate metal vessel walls, is non-contact, and is significantly lower in cost for continuous monitoring. The trade-off is spatial resolution, which is lower than medical CT — but for process imaging applications, the temporal resolution and operational simplicity are more important.

ECCT has been the subject of peer-reviewed clinical studies and published research demonstrating significant improvements in survival outcomes for certain cancer types, particularly advanced lung cancer. Clinical data presented at international oncology conferences has shown survival improvements of 600–800% compared to standard therapy alone when ECCT is used as an adjunct treatment. It is available through our Cancer Therapy Lab service centre and continues to be evaluated in further clinical settings.

The most extensively studied application is advanced-stage lung cancer, where ECCT has been used alongside standard chemotherapy and radiotherapy protocols. Research into breast, brain, and other solid tumour types is ongoing. For current availability and eligibility, please contact our Cancer Therapy Lab directly.

Yes. The ECVT Healthcare System uses no ionizing radiation — unlike X-ray, CT, or nuclear imaging — making it safe for repeated use, continuous monitoring, and use in populations where radiation exposure must be minimised (paediatric patients, pregnant patients, etc.). The sensor fields are low-energy and non-destructive to biological tissue.

CTECH Labs has worked with a range of academic and institutional partners including Ohio State University, Kyoto University, Chiba University, Universitas Gadjah Mada, Institut Teknologi Bandung, NASA, and the US Department of Energy. Collaborations span fundamental physics research, applied engineering, and clinical evaluation of our technologies.

Our Publications page lists selected peer-reviewed papers, conference proceedings, and research outputs. For full access to papers published in international journals, we recommend searching IEEE Xplore, PubMed, or Google Scholar using "ECVT", "ECCT", or "C-Tech Labs" as search terms.

We welcome enquiries from industrial partners, hospitals, universities, and research organisations. The best first step is to reach out via our contact page with a brief description of your application or interest area. Our team will follow up to discuss feasibility and next steps.